Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1999 Jun 15;160(12):1738–1742.

Canadian Consensus Conference on Dementia: a physician's guide to using the recommendations

C J Patterson 1, S Gauthier 1, H Bergman 1, C A Cohen 1, J W Feightner 1, H Feldman 1, D B Hogan 1
PMCID: PMC1230413  PMID: 10410640

Full Text

The Full Text of this article is available as a PDF (115.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brenner D. E., Kukull W. A., Stergachis A., van Belle G., Bowen J. D., McCormick W. C., Teri L., Larson E. B. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol. 1994 Aug 1;140(3):262–267. doi: 10.1093/oxfordjournals.aje.a117245. [DOI] [PubMed] [Google Scholar]
  2. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  3. Forette F., Seux M. L., Staessen J. A., Thijs L., Birkenhäger W. H., Babarskiene M. R., Babeanu S., Bossini A., Gil-Extremera B., Girerd X. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998 Oct 24;352(9137):1347–1351. doi: 10.1016/s0140-6736(98)03086-4. [DOI] [PubMed] [Google Scholar]
  4. Freter S., Bergman H., Gold S., Chertkow H., Clarfield A. M. Prevalence of potentially reversible dementias and actual reversibility in a memory clinic cohort. CMAJ. 1998 Sep 22;159(6):657–662. [PMC free article] [PubMed] [Google Scholar]
  5. Heyman A., Peterson B., Fillenbaum G., Pieper C. The consortium to establish a registry for Alzheimer's disease (CERAD). Part XIV: Demographic and clinical predictors of survival in patients with Alzheimer's disease. Neurology. 1996 Mar;46(3):656–660. doi: 10.1212/wnl.46.3.656. [DOI] [PubMed] [Google Scholar]
  6. Katz I. R., Jeste D. V., Mintzer J. E., Clyde C., Napolitano J., Brecher M. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry. 1999 Feb;60(2):107–115. doi: 10.4088/jcp.v60n0207. [DOI] [PubMed] [Google Scholar]
  7. Nilsson K., Palmstierna T., Wistedt B. Aggressive behavior in hospitalized psychogeriatric patients. Acta Psychiatr Scand. 1988 Aug;78(2):172–175. doi: 10.1111/j.1600-0447.1988.tb06318.x. [DOI] [PubMed] [Google Scholar]
  8. Shea C., MacKnight C., Rockwood K. Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients. Int Psychogeriatr. 1998 Sep;10(3):229–238. doi: 10.1017/s1041610298005341. [DOI] [PubMed] [Google Scholar]
  9. Snowdon D. A., Greiner L. H., Mortimer J. A., Riley K. P., Greiner P. A., Markesbery W. R. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997 Mar 12;277(10):813–817. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES